Swiss National Bank
MACK

Swiss National Bank’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Swiss National Bank’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-25,661
Closed -$294K – 2593
2017
Q3 		$294K Hold
25,661
– – ﹤0.01% 2489
2017
Q2 		$250K Hold
25,661
– – ﹤0.01% 2541
2017
Q1 		$622K Hold
25,661
– – ﹤0.01% 2282
2016
Q4 		$824K Buy
25,661
+2,071
+9% +$88.3K ﹤0.01% 2152
2016
Q3 		$1.18M Hold
23,590
– – ﹤0.01% 1862
2016
Q2 		$1M Buy
23,590
+1,220
+5% +$66.5K ﹤0.01% 1965
2016
Q1 		$1.42M Buy
22,370
+4,970
+29% +$259K ﹤0.01% 1671
2015
Q4 		$1.08M Hold
17,400
– – ﹤0.01% 1767
2015
Q3 		$1.17M Buy
17,400
+2,415
+16% +$197K ﹤0.01% 1680
2015
Q2 		$1.46M Buy
14,985
+343
+2% +$32.6K ﹤0.01% 1546
2015
Q1 		$1.37M Buy
14,642
+496
+4% +$42.2K ﹤0.01% 1557
2014
Q4 		$1.26M Hold
14,146
– – ﹤0.01% 1587
2014
Q3 		$977K Hold
14,146
– – ﹤0.01% 1675
2014
Q2 		$811K Hold
14,146
– – ﹤0.01% 1849
2014
Q1 		$561K Buy
14,146
+2,402
+20% +$103K ﹤0.01% 2066
2013
Q4 		$493K Hold
11,744
– – ﹤0.01% 1998
2013
Q3 		$351K Buy
11,744
+839
+8% +$29.4K ﹤0.01% 2149
2013
Q2 		$577K Buy
+10,905
New +$478K ﹤0.01% 1809

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Swiss National Bank's MACK Position: Q4 2017 in Review

Swiss National Bank sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q4 2017, closing a stake of 25,661 shares — an estimated $294K sold.

Swiss National Bank first reported a position in MACK in Q2 2013 and held it in 18 quarters. The position peaked at $1.46M in Q2 2015. 78 funds tracked by Wall St. Rank hold MACK as of Q4 2017.

  • Swiss National Bank reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • Swiss National Bank sold 25,661 Merrimack Pharmaceuticals, Inc. shares in Q4 2017, an estimated $294K.
  • Swiss National Bank first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and held it in 18 quarters.
  • Swiss National Bank's Merrimack Pharmaceuticals, Inc. position peaked at $1.46M in Q2 2015.
  • 78 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2017.

Based on Swiss National Bank's 13F filing for Q4 2017, filed 7 Feb 2018.